{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:25:40Z","timestamp":1771647940586,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":109,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Im Kindes- und Jugendalter ist, im Gegensatz zum Erwachsenenalter, der Diabetes mellitus Typ\u00a01 (T1D) die am h\u00e4ufigsten auftretende Form des Diabetes mellitus (&gt;\u202f90\u202f%). Nach der Diagnosestellung sollte die Betreuung der Kinder und Jugendlichen in einem p\u00e4diatrischen Zentrum mit viel Erfahrung in p\u00e4diatrischer Diabetologie erfolgen. Eine lebenslange Insulintherapie ist notwendig, wobei diese individuell an das Alter und den Alltag der Familie angepasst werden soll. In diesem Alter wird ausdr\u00fccklich die Verwendung von Diabetestechnologie (Sensorglukosemessung, Insulinpumpentherapie und seit kurzem eine Hybrid-Closed-Loop-Therapie) empfohlen. Eine m\u00f6glichst optimale metabolische Einstellung ab Therapiebeginn verbessert die Langzeitprognose der jungen Menschen mit Diabetes. Ein wesentlicher Teil in der Betreuung ist die Schulung von PatientInnen und Eltern von einem entsprechend ausgebildeten multidisziplin\u00e4ren Team, bestehend aus p\u00e4diatrischen DiabetologInnen, DiabetesberaterInnen, Di\u00e4tologInnen, PsychologInnen und SozialarbeiterInnen. Die APED\u00d6 (Arbeitsgruppe f\u00fcr p\u00e4diatrische Endokrinologie und Diabetologie \u00d6sterreich) und die ISPAD (International Society for Pediatric and Adolescent Diabetes) empfehlen als metabolisches Ziel f\u00fcr alle p\u00e4diatrischen Altersgruppen einen HbA<jats:sub>1c<\/jats:sub>-Wert \u2264\u202f7,0\u202f% (IFCC \u2264\u202f53\u202fmmol\/mol) mit einer \u201eTime in Range\u201c (TIR) &gt;\u202f70\u202f% ohne schwere Hypoglyk\u00e4mien. Eine altersentsprechend normale k\u00f6rperliche, kognitive und psychosoziale Entwicklung sowie die Vermeidung von Akutkomplikationen (schwere Hypoglyk\u00e4mien, diabetische Ketoazidose), das Screening auf assoziierte Erkrankungen und die Pr\u00e4vention von diabetesbedingten Sp\u00e4tkomplikationen zum Erhalt einer hohen Lebensqualit\u00e4t sind die Ziele der p\u00e4diatrischen Diabetestherapie.<\/jats:p>","DOI":"10.1007\/s00508-023-02169-5","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T23:03:25Z","timestamp":1682550205000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diabetes mellitus im Kindes- und Jugendalter (Update\u00a02023)","Diabetes mellitus in childhood and adolescence (Update\u00a02023)"],"prefix":"10.1007","volume":"135","author":[{"given":"Birgit","family":"Rami-Merhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Fr\u00f6hlich-Reiterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine E.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"issue":"Suppl","key":"2169_CR1","first-page":"17","volume":"45","author":"D Care","year":"2022","unstructured":"Care\u00a0D, Suppl\u00a0SS. Classification and diagnosis of Diabetes: Standards of medical care in diabetes\u20142022. Diabetes Care. 2022;45(Suppl):17\u201338.","journal-title":"Diabetes Care"},{"issue":"8","key":"2169_CR2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/pedi.13454","volume":"23","author":"I Libman","year":"2022","unstructured":"Libman\u00a0I, Haynes\u00a0A, Lyons\u00a0S, Pradeep\u00a0P, Rwagasor\u00a0E, Tung\u00a0JY, Jefferies\u00a0CA, Oram\u00a0RA, Dabelea\u00a0D, Craig\u00a0ME. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1160\u201374.","journal-title":"Pediatr Diabetes"},{"key":"2169_CR3","first-page":"15","volume":"23","author":"B Rami-Merhar","year":"2022","unstructured":"Rami-Merhar\u00a0B, Hofer\u00a0SE, Fr\u00f6hlich-Reiterer\u00a0E, Waldh\u00f6r\u00a0T, Fritsch\u00a0M, Nagl\u00a0K. Ongoing increase in incidence of diabetes mellitus in Austrian children and adolescents < 15\u00a0years (1999\u20132021). Pediatr Diabetes. 2022;23:15. Special Issue: 48th Annual ISPAD Conference 2022.","journal-title":"Pediatr Diabetes"},{"key":"2169_CR4","doi-asserted-by":"publisher","first-page":"820156","DOI":"10.3389\/fped.2022.820156","volume":"10","author":"K Nagl","year":"2022","unstructured":"Nagl\u00a0K, Waldh\u00f6r\u00a0T, Hofer\u00a0SE, Fritsch\u00a0M, Meraner\u00a0D, Prchla\u00a0C, et al. Alarming increase of Ketoacidosis prevalence at type 1 diabetes-onset in Austria\u2014Results from a\u00a0nationwide registry. Front Pediatr. 2022;10:820156.","journal-title":"Front Pediatr"},{"key":"2169_CR5","doi-asserted-by":"publisher","first-page":"107842","DOI":"10.1016\/j.diabres.2019.107842","volume":"157","author":"CC Patterson","year":"2019","unstructured":"Patterson\u00a0CC, Karuranga\u00a0S, Salpea\u00a0P, Saeedi\u00a0P, Dahlquist\u00a0G, Soltesz\u00a0G, et\u00a0al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107842.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2169_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","volume":"62","author":"CC Patterson","year":"2019","unstructured":"Patterson\u00a0CC, Harjutsalo\u00a0V, Rosenbauer\u00a0J, Neu\u00a0A, Cinek\u00a0O, Skrivarhaug\u00a0T, et\u00a0al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25\u00a0year period 1989\u20132013: a\u00a0multicentre prospective registration study. Diabetologia. 2019;62(3):408\u201317.","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"2169_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00608-021-00873-x","volume":"56","author":"B Rami-Merhar","year":"2021","unstructured":"Rami-Merhar\u00a0B, L\u00fcck\u00a0U, Fritsch\u00a0M, Fr\u00f6hlich-Reiterer\u00a0E, Hofer\u00a0SE. Struktur der Betreuung von Kindern und Jugendlichen mit Diabetes mellitus. Paediatr Paedol. 2021;56(Suppl 1):5\u20137.","journal-title":"Paediatr Paedol"},{"issue":"S1","key":"2169_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00608-021-00882-w","volume":"56","author":"E Fr\u00f6hlich-Reiterer","year":"2021","unstructured":"Fr\u00f6hlich-Reiterer\u00a0E, Tauschmann\u00a0M, Rami-Merhar\u00a0B, Fritsch\u00a0M, Hofer\u00a0S. Therapie, Ziele und Insuline. Paediatr Paedolog. 2021;56(S1):15\u20138.","journal-title":"Paediatr Paedolog"},{"issue":"8","key":"2169_CR9","first-page":"1270","volume":"23","author":"M de Bock","year":"2022","unstructured":"de Bock\u00a0M, Codner\u00a0E, Craig\u00a0ME, Huynh\u00a0T, Maahs\u00a0DM, Mahmud\u00a0FH, Marcovecchio\u00a0L, DiMeglio\u00a0LA. ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr. Diabetes. 2022;23(8):1270\u20136.","journal-title":"Diabetes"},{"key":"2169_CR10","first-page":"6","volume-title":"General practice indicator for the NICE menu","author":"National Institute for Health and Care Excellence","year":"2017","unstructured":"National Institute for Health and Care Excellence. General practice indicator for the NICE menu. 2017. S.\u00a06\u20138."},{"issue":"2","key":"2169_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2337\/dc20-1978","volume":"44","author":"MJ Redondo","year":"2021","unstructured":"Redondo\u00a0MJ, Libman\u00a0I, Maahs\u00a0DM, Lyons\u00a0SK, Saraco\u00a0M, Reusch\u00a0J, et\u00a0al. The evolution of hemoglobin a1c targets for youth with type 1 diabetes: Rationale and supporting evidence. Diabetes Care. 2021;44(2):301\u201312.","journal-title":"Diabetes Care"},{"issue":"8","key":"2169_CR12","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino\u00a0T, Danne\u00a0T, Bergenstal\u00a0RM, Amiel\u00a0SA, Beck\u00a0R, Biester\u00a0T, et\u00a0al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593\u2013603.","journal-title":"Diabetes Care"},{"issue":"3","key":"2169_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2337\/dc18-1444","volume":"42","author":"RW Beck","year":"2019","unstructured":"Beck\u00a0RW, Bergenstal\u00a0RM, Riddlesworth\u00a0TD, Kollman\u00a0C, Li\u00a0Z, Brown\u00a0AS, et\u00a0al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2019;42(3):400\u20135.","journal-title":"Diabetes Care"},{"issue":"5","key":"2169_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11428-021-00769-1","volume":"17","author":"A Neu","year":"2021","unstructured":"Neu\u00a0A, B\u00fcrger-B\u00fcsing\u00a0J, Danne\u00a0T, Dost\u00a0A, Holder\u00a0M, Holl\u00a0RW, et al. Diagnosis, therapy and follow-up of diabetes mellitus in children and adolescents. Diabetologe. 2021;17(5):557\u201384.","journal-title":"Diabetologe"},{"issue":"14","key":"2169_CR15","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jama.2017.13994","volume":"318","author":"B Karges","year":"2017","unstructured":"Karges\u00a0B, Schwandt\u00a0A, Heidtmann\u00a0B, Kordonouri\u00a0O, Binder\u00a0E, Schierloh\u00a0U, et\u00a0al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. J\u00a0Am Med Assoc. 2017;318(14):1358\u201366.","journal-title":"J Am Med Assoc"},{"issue":"15","key":"2169_CR16","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani\u00a0A, Rawshani\u00a0A, Franz\u00e9n\u00a0S, Eliasson\u00a0B, Svensson\u00a0AM, Miftaraj\u00a0M, McGuire\u00a0DK, Sattar\u00a0N, Rosengren\u00a0A, Soff\u00a0PD. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N\u00a0Engl J Med. 2017;376(15):1407\u201318.","journal-title":"N Engl J Med"},{"issue":"9","key":"2169_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMoa2004736","volume":"383","author":"MD Breton","year":"2020","unstructured":"Breton\u00a0MD, Kanapka\u00a0LG, Beck\u00a0RW, Ekhlaspour\u00a0L, Forlenza\u00a0GP, Cengiz\u00a0E, et al. A randomized trial of closed-loop control in children with type 1 diabetes. N\u00a0Engl J Med. 2020;383(9):836\u201345.","journal-title":"N Engl J Med"},{"issue":"3","key":"2169_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa2111673","volume":"386","author":"J Ware","year":"2022","unstructured":"Ware\u00a0J, Allen\u00a0JM, Boughton\u00a0CK, Wilinska\u00a0ME, Hartnell\u00a0S, Thankamony\u00a0A, et al. Randomized trial of closed-loop control in very young children with type 1 diabetes. N\u00a0Engl J Med. 2022;386(3):209\u201319.","journal-title":"N Engl J Med"},{"issue":"4","key":"2169_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2337\/dc20-2250","volume":"44","author":"OJ Collyns","year":"2021","unstructured":"Collyns\u00a0OJ, Meier\u00a0RA, Betts\u00a0ZL, Chan\u00a0DSH, Frampton\u00a0C, Frewen\u00a0CM, et al. Improved glycemic outcomes with medtronic minimed advanced hybrid closed-loop delivery: Results from a\u00a0randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in peoplewithtype1diabetes. Diabetes Care. 2021;44(4):969\u201375.","journal-title":"Diabetes Care"},{"issue":"5","key":"2169_CR20","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jpeds.2014.07.001","volume":"165","author":"SE Hofer","year":"2014","unstructured":"Hofer\u00a0SE, Raile\u00a0K, Fr\u00f6hlich-Reiterer\u00a0E, Kapellen\u00a0T, Dost\u00a0A, Rosenbauer\u00a0J, et al. Tracking of metabolic control from childhood to young adulthood in type 1 diabetes. J\u00a0Pediatr. 2014;165(5):956\u2013961.e2.","journal-title":"J Pediatr"},{"issue":"3","key":"2169_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/pedi.12085","volume":"15","author":"U Samuelsson","year":"2014","unstructured":"Samuelsson\u00a0U, Steineck\u00a0I, Gubbjornsdottir\u00a0S. A high mean-HbA1c value 3\u201315\u00a0months after diagnosis of type 1 diabetes in childhood is related to metabolic control, macroalbuminuria, and retinopathy in early adulthood\u2011a pilot study using two nation-wide population based quality registries. Pediatr Diabetes. 2014;15(3):229\u201335.","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"2169_CR22","first-page":"494","volume":"20","author":"V Mazarello Paes","year":"2019","unstructured":"Mazarello Paes\u00a0V, Barrett\u00a0JK, Taylor-Robinson\u00a0DC, Chesters\u00a0H, Charalampopoulos\u00a0D, Dunger\u00a0DB, et al. Effect of early glycemic control on HbA1c tracking and development of vascular complications after 5\u00a0years of childhood onset type 1 diabetes: Systematic review and meta-analysis. Pediatr Diabetes. 2019;20(5):494\u2013509.","journal-title":"Pediatr Diabetes"},{"issue":"January","key":"2169_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2337\/dc20-1205","volume":"43","author":"D Care","year":"2020","unstructured":"Care\u00a0D, Suppl\u00a0SS. Children and adolescents: Standards of medical care in diabetes\u20142020. Diabetes Care. 2020;43(January):163\u201382.","journal-title":"Diabetes Care"},{"issue":"7","key":"2169_CR24","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/pedi.13409","volume":"23","author":"AS Shah","year":"2022","unstructured":"Shah\u00a0AS, Zeitler\u00a0PS, Wong\u00a0J, Pena\u00a0AS, Wicklow\u00a0B, Arslanian\u00a0S, Chang\u00a0N, Fu\u00a0J, Dabadghao\u00a0P, Pinhas-Hamiel\u00a0O, Urakami\u00a0T, Craig\u00a0ME. ISPAD clinical practice consensus guidelines 2022: type 2 diabetes in children and adolescents. Pediatr Diabetes. 2022;23(7):872\u2013902.","journal-title":"Pediatr Diabetes"},{"issue":"S1","key":"2169_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00608-021-00880-y","volume":"56","author":"S Judmaier","year":"2021","unstructured":"Judmaier\u00a0S, Kovac\u00a0U. Ern\u00e4hrungsempfehlungen bei Kindern und Jugendlichen mit Diabetes mellitus Typ1. Paediatr Paedolog. 2021;56(S1):8\u201312.","journal-title":"Paediatr Paedolog"},{"issue":"8","key":"2169_CR26","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/pedi.13443","volume":"23","author":"MB Abraham","year":"2022","unstructured":"Abraham\u00a0MB, Karges\u00a0B, Dovc\u00a0K, Naranjo\u00a0D, Arbelaez\u00a0AM, Mbogo\u00a0J, Javelikar\u00a0G, Jones\u00a0TW, Mahmud\u00a0FH. ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1322\u201340.","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"2169_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/pedi.13406","volume":"23","author":"N Glaser","year":"2022","unstructured":"Glaser\u00a0N, Fritsch\u00a0M, Priyambada\u00a0L, Rewers\u00a0A, Cherubini\u00a0V, Estrada\u00a0S, Wolfsdorf\u00a0JI, Codner\u00a0E. ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23(7):835\u201356.","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"2169_CR28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/pedi.13445","volume":"23","author":"E Fr\u00f6hlich-Reiterer","year":"2022","unstructured":"Fr\u00f6hlich-Reiterer\u00a0E, Elbarbary\u00a0NS, Simmons\u00a0K, Buckingham\u00a0B, Humayun\u00a0KN, Johannsen\u00a0J, Holl\u00a0RW, Betz\u00a0S, Mahmud\u00a0FH. ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2022;23(8):1451\u201367.","journal-title":"Pediatr Diabetes"},{"issue":"S1","key":"2169_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00608-021-00888-4","volume":"56","author":"E Fr\u00f6hlich-Reiterer","year":"2021","unstructured":"Fr\u00f6hlich-Reiterer\u00a0E, Hofer\u00a0S, Jasser-Nitsche\u00a0H, L\u00fcck\u00a0U, Rami-Merhar\u00a0B. Assoziierte Erkrankungen und andere Komplikationen. Paediatr Paedolog. 2021;56(S1):33\u20137.","journal-title":"Paediatr Paedolog"},{"issue":"8","key":"2169_CR30","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/pedi.13444","volume":"23","author":"P Bjornstad","year":"2022","unstructured":"Bjornstad\u00a0P, Dart\u00a0A, Donaghue\u00a0KC, Dost\u00a0A, Feldman\u00a0EL, Tan\u00a0GS, Wadwa\u00a0RP, Zabeen\u00a0B, Marcovecchio\u00a0ML. ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1432\u201350.","journal-title":"Pediatr Diabetes"},{"issue":"S1","key":"2169_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00608-021-00889-3","volume":"56","author":"M Fritsch","year":"2021","unstructured":"Fritsch\u00a0M, Nagl\u00a0K, Rojacher\u00a0T, Dorninger\u00a0L, Hofer\u00a0S, Fr\u00f6hlich-Reiterer\u00a0E. Sp\u00e4tkomplikationen. Paediatr Paedolog. 2021;56(S1):38\u201342.","journal-title":"Paediatr Paedolog"},{"issue":"1","key":"2169_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","volume":"70","author":"S Husby","year":"2020","unstructured":"Husby\u00a0S, Koletzko\u00a0S, Korponay-Szab\u00f3\u00a0I, Kurppa\u00a0K, Mearin\u00a0ML, Ribes-Koninckx\u00a0C, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J\u00a0Pediatr Gastroenterol Nutr. 2020;70(1):141\u201356.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"2169_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/pedi.13408","volume":"23","author":"JW Gregory","year":"2022","unstructured":"Gregory\u00a0JW, Cameron\u00a0FJ, Joshi\u00a0K, Eiswirth\u00a0M, Garrett\u00a0C, Garvey\u00a0K, Agarwal\u00a0S, Codner\u00a0E. ISPAD clinical practice consensus guidelines 2022: diabetes in adolescenc. Pediatr Diabetes. 2022;23(7):857\u201371.","journal-title":"Pediatr Diabetes"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02169-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-023-02169-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02169-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T23:06:42Z","timestamp":1682550402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-023-02169-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":33,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2169"],"URL":"https:\/\/doi.org\/10.1007\/s00508-023-02169-5","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"22 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.\u00a0Rami-Merhar hat in den letzten 36\u00a0Monaten von folgenden Firmen Honorare\/Forschungsgelder erhalten: Eli Lilly, Medtronic, Insulet, Abbott, Sanofi. E.\u00a0Fr\u00f6hlich-Reiterer hat in den letzten 36\u00a0Monaten von folgenden Firmen Vortragshonorare, Forschungsgelder und Honorare f\u00fcr Beratungst\u00e4tigkeit erhalten: Medtronic, Novo Nordisk, Eli Lilly, Sanofi und Merck. S.E.\u00a0Hofer erkl\u00e4rt in den letzten 3\u00a0Jahren Vortragshonorare der Firmen E.\u00a0Lilly, Medtronic, Insulet, Dexcom und Ypsomed erhalten zu haben. M.\u00a0Fritsch gibt an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}